These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 2946759)

  • 61. Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII.
    Davies J; Jiang L; Pan LZ; LaBarre MJ; Anderson D; Reff M
    Biotechnol Bioeng; 2001 Aug; 74(4):288-94. PubMed ID: 11410853
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The valence for ligand of the human mononuclear phagocyte 72 kD high-affinity IgG Fc receptor is one.
    O'Grady JH; Looney RJ; Anderson CL
    J Immunol; 1986 Oct; 137(7):2307-10. PubMed ID: 3093571
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Distinctive role of IgG1 and IgG3 isotypes in Fc gamma R-mediated functions.
    Rozsnyay Z; Sármay G; Walker M; Maslanka K; Valasek Z; Jefferis R; Gergely J
    Immunology; 1989 Apr; 66(4):491-8. PubMed ID: 2523858
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Monoclonal antibody to the type II Fc receptor for human IgG blocks potentiation of monocyte and neutrophil IgG-induced respiratory burst activation by aggregated C-reactive protein.
    Zeller JM; Sullivan BL
    Cell Immunol; 1993 Jun; 149(1):144-54. PubMed ID: 8513509
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cross-reaction of a rat-anti-mouse phagocyte-specific monoclonal antibody (anti-Mac-1) with human monocytes and natural killer cells.
    Ault KA; Springer TA
    J Immunol; 1981 Jan; 126(1):359-64. PubMed ID: 7451976
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phorbol esters enhance spontaneous cytotoxicity of human lymphocytes, abrogate Fc receptor expression, and inhibit antibody-dependent lymphocyte-mediated cytotoxicity.
    Trinchieri G; O'Brien T; Shade M; Perussia B
    J Immunol; 1984 Oct; 133(4):1869-77. PubMed ID: 6432902
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Characterization of a new monoclonal anti-Fc gamma RII antibody, AT10, and its incorporation into a bispecific F(ab')2 derivative for recruitment of cytotoxic effectors.
    Greenman J; Tutt AL; George AJ; Pulford KA; Stevenson GT; Glennie MJ
    Mol Immunol; 1991 Nov; 28(11):1243-54. PubMed ID: 1835758
    [TBL] [Abstract][Full Text] [Related]  

  • 68. IFN-gamma treated monocyte/macrophage phagocytosis of red cells sensitized with IgG1 and IgG3 Anti-D containing identical immunoglobulin variable region genes.
    Perri D; Shabani F; Ziaeian G; Denomme GA
    Transfus Apher Sci; 2008 Aug; 39(1):37-44. PubMed ID: 18614400
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.
    Kanda Y; Yamada T; Mori K; Okazaki A; Inoue M; Kitajima-Miyama K; Kuni-Kamochi R; Nakano R; Yano K; Kakita S; Shitara K; Satoh M
    Glycobiology; 2007 Jan; 17(1):104-18. PubMed ID: 17012310
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Interferon-gamma treatment impairs Fc receptor type II-mediated phagocytosis of human macrophages by a post-receptor-binding mechanism.
    Jungi TW; Brcic M; Leutwyler C; Pfister H; Spycher MO
    Immunology; 1991 Nov; 74(3):439-45. PubMed ID: 1837536
    [TBL] [Abstract][Full Text] [Related]  

  • 71. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
    Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
    Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
    [TBL] [Abstract][Full Text] [Related]  

  • 72. My 43, a monoclonal antibody that reacts with human myeloid cells inhibits monocyte IgA binding and triggers function.
    Shen L; Lasser R; Fanger MW
    J Immunol; 1989 Dec; 143(12):4117-22. PubMed ID: 2556475
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nonfucosylated therapeutic IgG1 antibody can evade the inhibitory effect of serum immunoglobulin G on antibody-dependent cellular cytotoxicity through its high binding to FcgammaRIIIa.
    Iida S; Misaka H; Inoue M; Shibata M; Nakano R; Yamane-Ohnuki N; Wakitani M; Yano K; Shitara K; Satoh M
    Clin Cancer Res; 2006 May; 12(9):2879-87. PubMed ID: 16675584
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Accelerated internalization and detoxification of endotoxin by anti-lipopolysaccharide antibody is an Fc receptor--mediated process.
    Lazaron V; Leslie DB; Wasiluk KR; Dunn DL
    Surgery; 2001 Aug; 130(2):192-7. PubMed ID: 11490348
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Biologic effects of gamma interferon pre-treatment followed by monoclonal antibody 17-1A administration in patients with gastrointestinal carcinoma.
    Weiner LM; Steplewski Z; Koprowski H; Sears HF; Litwin S; Comis RL
    Hybridoma; 1986 Jul; 5 Suppl 1():S65-77. PubMed ID: 3091476
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Blockade of Fc receptor-mediated binding to U-937 cells by murine monoclonal antibodies directed against a variety of surface antigens.
    Kurlander RJ
    J Immunol; 1983 Jul; 131(1):140-7. PubMed ID: 6223069
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Regulation of Fc epsilon receptor expression on a human monoblast cell line U937.
    Mayumi M; Kawabe T; Kim KM; Heike T; Katamura K; Yodoi J; Mikawa H
    Clin Exp Immunol; 1988 Jan; 71(1):202-6. PubMed ID: 2964957
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human monocyte cytotoxicity to tumor cells. I. Antibody-dependent cytotoxicity.
    Shaw GM; Levy PC; Lobuglio AF
    J Immunol; 1978 Aug; 121(2):573-8. PubMed ID: 79607
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Natural killer (NK) activity in human responders and nonresponders to stimulation by anti-CD16 antibodies.
    Galatiuc C; Gherman M; Metes D; Sulica A; DeLeo A; Whiteside TL; Herberman RB
    Cell Immunol; 1995 Jul; 163(2):167-77. PubMed ID: 7606790
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Comparative efficiencies of bispecific F(ab'gamma)2 and chimeric mouse/human IgG antibodies in recruiting cellular effectors for cytotoxicity via Fc gamma receptors.
    Greenman J; Hogg N; Nikoletti S; Slade C; Stevenson G; Glennie M
    Cancer Immunol Immunother; 1992; 34(6):361-9. PubMed ID: 1532922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.